This is a preview of subscription content, log in via an institution to check access.
Reference
Van Heteren P, et al. Pola-R-ICE: Results from the Interim Safety Analysis. Polatuzumab-vedotin in combination with rituximab, ifosfamide, carboplatin and etoposide (Pola-R-ICE) compared to R-ICE as salvage therapy in patients with primary refractory or relapsed diffuse large B-cell lymphoma (DLBCL). Oncology Research and Treatment 46 (Suppl.): 108-109 abstr. V829, Oct 2023. Available from: URL: https://dx.doi.org/10.1159/000533576 [abstract]
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 2000, 40 (2024). https://doi.org/10.1007/s40278-024-54729-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-024-54729-y